Lingor, Paul;Weber, Markus;Catnu, William;Friede, Tim;Hilgers, Reinhard;Leha, Andreas;Neuwirth, Christoph;Guenther, René;Benatar, Michael;Kuzma-Kozakiewicz, Magdalena;Bidner, Helen;Blankenstein, Christiane;Frontini, Roberto;Ludolph, Albert;Koch, Jan C.;Attarian, Shahram;Baehr, Mathias;Boentert, Matthias;Braun, Nathalie;Corcia, Philippe;Cordts, Isabell;Deschauer, Marcus;Grehl, Thorsten;Grosskreutz, Julian;Hermann, Andreas;Kuttler, Josua;Lengenfeldt, Teresa;Maass, Fabian;Meyer, Thomas;Petri, Susanne;Remane, Yvonne;Schmidt, Jens;Schuster, Joachim;Soriani, Marie-Hélène;Statland, Jeffrey;Weishaupt, Jochen;Zeller, Daniel;Zielke, Eirini.ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis.Front Neurol.2019.10

Tölle, T R;Baron, R;de Bock, E;Junor, R;Dias Barbosa, C;Marshall, S F;Arnould, B;Freynhagen, R.painPREDICT: first interim data from the development of a new patient-reported pain questionnaire to predict treatment response using sensory symptom profiles..Curr Med Res Opin.2019.35.7.1177-1185

Forbrig, Robert;Lockau, Hannah;Flottmann, Fabian;Boeckh-Behrens, Tobias;Kabbasch, Christoph;Patzig, Maximilian;Mpotsaris, Anastasios;Fiehler, Jens;Liebig, Thomas;Thomalla, Goetz;Onur, Oezguer A;Wunderlich, Silke;Kreiser, Kornelia;Herzberg, Moriz;Wollenweber, Frank A;Prothmann, Sascha;Dorn, Franziska.Intracranial Rescue Stent Angioplasty After Stent-Retriever Thrombectomy : Multicenter Experience..Clin Neuroradiol.2019.29.3.445-457

Meindl, T.;Li, Y.;Jochim, A.;Mantel, T.;Hapfelmeier, A.;Haslinger, B..Differential diagnosis of Parkinsonian Syndromes - combining clinical and imaging data in a machine-learning approach.Mov Disord.2019.34.S813-S813

Schmitz, Matthias;Villar-Piqué, Anna;Llorens, Franc;Gmitterová, Karin;Hermann, Peter;Varges, Daniela;Zafar, Saima;Lingor, Paul;Vanderstichele, Hugo;Demeyer, Leentje;Stoops, Erik;Trojanowski, John Q;Lee, Virginia M-Y;Zerr, Inga.Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt-Jakob Disease and Synucleinopathy..Mol Neurobiol.2019.56.5.3476-3483

Lingor, Paul;Roser, Anna-Elisa;Jain, Gaurav;Maass, Fabian;Gomes, Caldi Lucas;Bahr, Mathias;Fischer, Andre.Massive parallel small RNA sequencing identifies a specific miRNA signature in CSF of PD patients.J Neural Transm.2019.126.5.681-681

Maass, Fabian;Schulz, Isabel;Lingor, Paul;Mollenhauer, Brit;Bähr, Mathias.Cerebrospinal fluid biomarker for Parkinson's disease: An overview..Mol Cell Neurosci.2019.97.60-66

Straube, C.;Combs, S. E.;Gempt, J.;Meyer, B.;Zimmer, C.;Schmidt-Graf, F.;Vajkoczy, P.;Misch, M.;Gruen, A.;Budach, V;Kaul, D..Re-Irradiation of Glioblastomas after macroscopically complete Recurrence Resection - Pooled Analysis of two Centers.Strahlenther Onkol.2019.195.S120-S120

Boerger, Matthias;Funke, Sebastian;Leha, Andreas;Roser, Anna-Elisa;Wuestemann, Ann-Katrin;Maass, Fabian;Bähr, Mathias;Grus, Franz;Lingor, Paul.Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease - A pilot study..Parkinsonism Relat Disord.2019.63.3-9

Herrlinger, Ulrich;Tzaridis, Theophilos;Mack, Frederic;Steinbach, Joachim Peter;Schlegel, Uwe;Sabel, Michael;Hau, Peter;Kortmann, Rolf-Dieter;Krex, Dietmar;Grauer, Oliver;Goldbrunner, Roland;Schnell, Oliver;Bähr, Oliver;Uhl, Martin;Seidel, Clemens;Tabatabai, Ghazaleh;Kowalski, Thomas;Ringel, Florian;Schmidt-Graf, Friederike;Suchorska, Bogdana;Brehmer, Stefanie;Weyerbrock, Astrid;Renovanz, Miriam;Bullinger, Lars;Galldiks, Norbert;Vajkoczy, Peter;Misch, Martin;Vatter, Hartmut;Stuplich, Moritz;Schäfer, Niklas;Kebir, Sied;Weller, Johannes;Schaub, Christina;Stummer, Walter;Tonn, Jörg-Christian;Simon, Matthias;Keil, Vera C;Nelles, Michael;Urbach, Horst;Coenen, Martin;Wick, Wolfgang;Weller, Michael;Fimmers, Rolf;Schmid, Matthias;Hattingen, Elke;Pietsch, Torsten;Coch, Christoph;Glas, Martin.Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial..Lancet.2019.393.10172.678-688